DongSung Pharmaceutical, 25.39% Increase Amid COVID-19 (Dexamethasone) Theme Uptrend

On the 6th, the COVID-19 (Dexamethasone) theme rose by 3.59% compared to the previous day, showing strength, while Dongsung Pharmaceutical, which is attracting attention as a related stock, surged by 25.39% compared to the previous day. Dongsung Pharmaceutical is known as a manufacturer of pharmaceuticals and cosmetics such as the hair dye Seven Eight and Jeongrohwan.

[Graph] Major stock price changes in the COVID-19 (Dexamethasone) theme

According to preliminary data compiled at 14:28, foreigners are selling a large volume of Dongsung Pharmaceutical shares, with net foreign sales of -32,000 shares.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Dongsung Pharmaceutical's quant financial score is 9.66 points, which is lower in stability, profitability, and growth scores compared to the average of other stocks related to COVID-19 (Dexamethasone). This can be interpreted as Dongsung Pharmaceutical having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Huons ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.